Results
    Type
    Region
    Country of origin
    Qualifications

    Sodium iodide I-123 | compare suppliers & send inquiries for free

    Here you will find a list of producers, manufacturers and traders of Sodium iodide I-123. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
    India Infinium Pharma
    Type: Producer
    Produced in: India
    India
    New Zealand GE Healthcare
    Type: Producer
    Produced in: New Zealand
    New Zealand

    Looking for Sodium iodide I-123 ?

    API | Excipient name:
    Sodium iodide I-123 
    Synonyms:
     
    Cas Number:
     
    DrugBank number:
    DB09420 
    Unique Ingredient Identifier:
    29UKX3A616

    About Sodium iodide I-123

    Want to know what Iodide I-123 is used for? Iodide I-123 (as sodium Iodide I-123) is a radioactive isotope of iodine used in nuclear medicine for the diagnostic study of thyroid disease. Following oral administration, I-123 is absorbed through the gastrointestinal tract and is taken up by the thyroid gland. After incorporation, a gamma camera is used to detect the decay by electron capture to tellurium-123.

    Ask the supplier for a certificate of analysis to find out more about the quality of Iodide I-123.

    Sodium iodide I-123 manufacturers | traders | suppliers
    We have 2 companies offering Sodium iodide I-123 from 2 different countries.

    Get in contact with the supplier of your choice:

    • Infinium Pharma from India
    • GE Healthcare from New Zealand

    Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

    You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.